ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
96.63
+2.47 (2.62%)
Jun 26, 2026, 2:01 PM EDT - Market open
BIB Holdings Information
BIB is an equity ETF with a total of 261 individual holdings.
Total Holdings
261
Top 10 Percentage
158.60%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
69.83M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 41.30% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 29.22% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 23.90% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 21.88% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 20.83% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 5.25% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 4.72% |
| 8 | AMGN | Amgen Inc. | 4.64% |
| 9 | GILD | Gilead Sciences, Inc. | 4.14% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 2.72% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.66% |
| 12 | RVMD | Revolution Medicines, Inc. | 1.53% |
| 13 | BIIB | Biogen Inc. | 1.25% |
| 14 | ILMN | Illumina, Inc. | 1.12% |
| 15 | ROIV | Roivant Sciences Ltd. | 1.04% |
| 16 | RPRX | Royalty Pharma plc | 1.02% |
| 17 | MRNA | Moderna, Inc. | 1.02% |
| 18 | ARGX | argenx SE | 1.00% |
| 19 | UTHR | United Therapeutics Corporation | 0.99% |
| 20 | INSM | Insmed Incorporated | 0.95% |
| 21 | INCY | Incyte Corporation | 0.92% |
| 22 | VTRS | Viatris Inc. | 0.79% |
| 23 | GH | Guardant Health, Inc. | 0.77% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 0.71% |
| 25 | ASND | Ascendis Pharma A/S | 0.62% |
As of Jun 24, 2026